158 related articles for article (PubMed ID: 21407159)
1. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cyclooxygenase-1 and 2 gene expression levels in chronic autoimmune thyroiditis, papillary thyroid carcinoma and nontoxic nodular goitre.
Krawczyk-Rusiecka K; Wojciechowska-Durczynska K; Cyniak-Magierska A; Zygmunt A; Lewinski A
Thyroid Res; 2014; 7(1):10. PubMed ID: 25587354
[TBL] [Abstract][Full Text] [Related]
3. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.
Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S
Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355
[TBL] [Abstract][Full Text] [Related]
4. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
[TBL] [Abstract][Full Text] [Related]
5. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
Pelizzo MR; Boschin IM; Barollo S; Pennelli G; Toniato A; Zambonin L; Vianello F; Piotto A; Ide EC; Pagetta C; Sorgato N; Torresan F; Girelli ME; Nacamulli D; Mantero F; Mian C
Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
[TBL] [Abstract][Full Text] [Related]
6. Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR.
Wojciechowska-Durczyńska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Gałecka E; Lewiński A
Thyroid Res; 2010 Aug; 3(1):5. PubMed ID: 20804548
[TBL] [Abstract][Full Text] [Related]
7. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
8. Thyroglobulin Determination in Fine Needle Aspiration Biopsy Washout of Suspicious Lymph Nodes in Thyroid Carcinoma Follow up.
Achille G; Garrisi VM; Russo S; Guastamacchia E; Giagulli VA; Schirosi L; Daniele A; Tufaro A; Cafagna V; Centrone M; Simone G; Abbate I; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):213-218. PubMed ID: 28558632
[TBL] [Abstract][Full Text] [Related]
9. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM
Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
[TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma: an easy fine needle aspiration biopsy diagnosis?
Dušková J; Tretiník P
Acta Cytol; 2011; 55(2):120-30. PubMed ID: 21325795
[TBL] [Abstract][Full Text] [Related]
11. Cribriform-morular variant of papillary thyroid carcinoma: a study of 3 cases featuring the PIK3CA mutation.
Kwon MJ; Rho YS; Jeong JC; Shin HS; Lee JS; Cho SJ; Nam ES
Hum Pathol; 2015 Aug; 46(8):1180-8. PubMed ID: 26054797
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population.
Abubaker J; Jehan Z; Bavi P; Sultana M; Al-Harbi S; Ibrahim M; Al-Nuaim A; Ahmed M; Amin T; Al-Fehaily M; Al-Sanea O; Al-Dayel F; Uddin S; Al-Kuraya KS
J Clin Endocrinol Metab; 2008 Feb; 93(2):611-8. PubMed ID: 18000091
[TBL] [Abstract][Full Text] [Related]
13. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
14. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.
Xing M; Tufano RP; Tufaro AP; Basaria S; Ewertz M; Rosenbaum E; Byrne PJ; Wang J; Sidransky D; Ladenson PW
J Clin Endocrinol Metab; 2004 Jun; 89(6):2867-72. PubMed ID: 15181070
[TBL] [Abstract][Full Text] [Related]
15. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
Meng Z; Lu J; Wu H; Zhao Y; Luo Y; Gao J; Zhu Q; Jiang Y; Li W; Liang Z
Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026
[TBL] [Abstract][Full Text] [Related]
16. Cytologic features of focal papillary thyroid carcinoma arising within follicular adenoma: a masked cytomorphologic analysis of 17 cases.
Ono JC; Wilbur DC; Lee H; Yang J; Krane JF; Bongiovanni M; Faquin WC
Acta Cytol; 2011; 55(6):531-8. PubMed ID: 22156462
[TBL] [Abstract][Full Text] [Related]
17. Molecular analyses of thyroid tumors for diagnosis of malignancy on fine-needle aspiration biopsies and for prognosis of invasiveness on surgical specimens.
Rousset B; Ziercher L; Borson-Chazot F
Ann Endocrinol (Paris); 2011 Apr; 72(2):125-8. PubMed ID: 21511245
[TBL] [Abstract][Full Text] [Related]
18. Lymph node fine-needle aspiration washout thyroglobulin in papillary thyroid cancer: Diagnostic value and the effect of thyroglobulin antibodies.
Konca Degertekin C; Yalcin MM; Cerit T; Ozkan C; Kalan I; Iyidir OT; Altinova AE; Akturk M; Toruner F; Akin M; Cakir N
Endocr Res; 2016 Nov; 41(4):281-289. PubMed ID: 26905960
[TBL] [Abstract][Full Text] [Related]
19. PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.
Xu J; Cai J; Jin X; Yang J; Shen Q; Ding X; Liang Y
Oncol Rep; 2015 Sep; 34(3):1424-30. PubMed ID: 26133772
[TBL] [Abstract][Full Text] [Related]
20. FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation.
Pusztaszeri MP; Krane JF; Cibas ES; Daniels G; Faquin WC
Cancer Cytopathol; 2014 Sep; 122(9):666-77. PubMed ID: 24891128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
